94 related articles for article (PubMed ID: 2456096)
1. Interaction between platelet receptor and iloprost isomers.
Tsai AL; Vijjeswarapu H; Wu KK
Biochim Biophys Acta; 1988 Jul; 942(2):220-6. PubMed ID: 2456096
[TBL] [Abstract][Full Text] [Related]
2. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
3. Internalization and down-regulation of the prostacyclin receptor in human platelets.
Giovanazzi S; Accomazzo MR; Letari O; Oliva D; Nicosia S
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):71-7. PubMed ID: 9224631
[TBL] [Abstract][Full Text] [Related]
4. Solubilization of prostacyclin membrane receptors from human platelets.
Tsai AL; Hsu MJ; Vijjeswarapu H; Wu KK
J Biol Chem; 1989 Jan; 264(1):61-7. PubMed ID: 2642482
[TBL] [Abstract][Full Text] [Related]
5. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells.
Hall JM; Strange PG
Biosci Rep; 1984 Nov; 4(11):941-8. PubMed ID: 6084527
[TBL] [Abstract][Full Text] [Related]
6. Prostacyclin receptor desensitization is a reversible phenomenon in human platelets.
Fisch A; Tobusch K; Veit K; Meyer J; Darius H
Circulation; 1997 Aug; 96(3):756-60. PubMed ID: 9264479
[TBL] [Abstract][Full Text] [Related]
7. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
Darius H; Binz C; Veit K; Fisch A; Meyer J
J Am Coll Cardiol; 1995 Sep; 26(3):800-6. PubMed ID: 7543911
[TBL] [Abstract][Full Text] [Related]
8. Investigation of selective [3H]iloprost binding sites on human platelet membranes.
Steurer G; Jankovic B; Ettl K; Schernthaner G
Prog Clin Biol Res; 1987; 242():25-34. PubMed ID: 2444987
[No Abstract] [Full Text] [Related]
9. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.
Kajikawa N; Nogimori K; Murata T; Nishio S; Uchiyama S
Arzneimittelforschung; 1989 Apr; 39(4):495-9. PubMed ID: 2665758
[TBL] [Abstract][Full Text] [Related]
10. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
11. Identification of the prostacyclin receptor by radiation inactivation.
Leigh PJ; Cramp WA; MacDermot J
J Biol Chem; 1984 Oct; 259(20):12431-6. PubMed ID: 6208187
[TBL] [Abstract][Full Text] [Related]
12. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
Merritt JE; Brown AM; Bund S; Cooper DG; Egan JW; Hallam TJ; Heagerty AM; Hickey DM; Kaumann AJ; Keen M
Br J Pharmacol; 1991 Jan; 102(1):260-6. PubMed ID: 2043927
[TBL] [Abstract][Full Text] [Related]
13. Diminished inhibition of adhesion molecule expression in prostacyclin receptor desensitized human platelets.
Darius H; Veit K; Binz C; Fisch A; Meyer J
Agents Actions Suppl; 1995; 45():77-83. PubMed ID: 7536385
[TBL] [Abstract][Full Text] [Related]
14. Modulation of platelet [3H] iloprost binding by cholesterol, dibucaine and pentoxifylline.
Jaschonek K; Funck M; Muller CP; Schmidt H
Prog Clin Biol Res; 1989; 301():321-5. PubMed ID: 2477853
[No Abstract] [Full Text] [Related]
15. Human prostacyclin platelet receptors and platelet lipid composition.
Modesti PA; Abbate R; Prisco D; Gensini GF
J Lipid Mediat; 1990; 2(6):309-15. PubMed ID: 2133274
[TBL] [Abstract][Full Text] [Related]
16. Platelet PGI2 receptor affinity is reduced in pre-eclampsia.
Klockenbusch W; Hohlfeld T; Wilhelm M; Somville T; Schrör K
Br J Clin Pharmacol; 1996 Jun; 41(6):616-8. PubMed ID: 8799531
[TBL] [Abstract][Full Text] [Related]
17. Modulation of surface expression of human platelet prostacyclin receptors by cholesterol, dibucaine and pentoxifylline.
Funck M; Muller CP; Jaschonek K
Thromb Res; 1988 Nov; 52(4):343-7. PubMed ID: 2462288
[No Abstract] [Full Text] [Related]
18. Stabilization mechanism of prostacyclin by human serum: an approach by binding kinetics using a stable prostaglandin I2 analogue, iloprost.
Tsai AL; Wu KK
Biochim Biophys Acta; 1987 Apr; 924(1):67-74. PubMed ID: 2435326
[TBL] [Abstract][Full Text] [Related]
19. Heterologous desensitization of platelet adenosine (A2) responses by iloprost.
MacDermot J; Wilkins AJ; Edwards RJ
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():479-81. PubMed ID: 2444081
[No Abstract] [Full Text] [Related]
20. [3H]iloprost and prostaglandin E2 compete for the same receptor site on cardiac sarcolemmal membranes.
Lerner RW; Lopaschuk GD; Catena RC; Olley PM
Biochim Biophys Acta; 1992 Apr; 1105(2):189-92. PubMed ID: 1375098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
